The analysis by NGS of samples from 66 Chinese patients with CCA (44 iCCAs and 22 eCCAs) identified mutations in the AXIN2 gene only in two of these patients (3%), both female, one of each type of tumor, and alterations were associated with tumor mutational burden [52]. This evidence concerns the gene AXIN2 and cholangiocarcinoma.